Trials / Unknown
UnknownNCT05442307
Academic Detailing About Asthma
Boosting General Practice pRescription by Individual Educational Fast Academic Detailing Visits About Asthma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- Sponsor
- University Hospital Bispebjerg and Frederiksberg · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
General practices in the Capital Region of Denmark are offered a short educational visit and are randomized to either asthma (intervention) or another topic (control). The change in prescription pattern from before to after the visit is compared between the intervention and control group.
Detailed description
General practices in the Capital Region of Denmark are offered a short educational visit. They are randomized by address to be offered a visit about either asthma (intervention) or another topic (control). The prescription pattern of each general practice (as seen by their regional registration number \[ydernummer\]) who receive a visit is investigated. The change in prescription pattern from before to after the visit is compared between the intervention and control group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | asthma education | A 15 minutes (preferable) one-on-one educational visit about asthma treatment. The main points being: Every person with asthma should be treated with inhaled corticosteroids (ICS). Most patients with asthma should be treated with Bufomix Easyhaler either as needed and/or regularly. Patients should not use short-acting bega2-agonist (SABA) unless they use a medium-ICS-dosis. |
| BEHAVIORAL | Other education | A 15 minutes (preferable) one-on-one educational visit about another topic (NOT asthma). |
Timeline
- Start date
- 2021-10-06
- Primary completion
- 2023-11-01
- Completion
- 2023-11-01
- First posted
- 2022-07-05
- Last updated
- 2022-07-05
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05442307. Inclusion in this directory is not an endorsement.